<DOC>
	<DOCNO>NCT01709773</DOCNO>
	<brief_summary>This pilot cohort study woman undergo focal ablation high-grade cervical intraepithelial neoplasia ( HGCIN ) . The cohort recruit UCSF Dysplasia Clinics . The standard treatment involve treatment entire cervix . Women HGCIN meeting inclusion criterion recruit enrollment pilot study focal treatment . Upon enrollment , underwent focal ablational treatment rather standard ablational treatment cervix . Follow-up visit conduct 2 week 6 month assess safety , feasibility , acceptability . The 6-month recurrence rate HGCIN calculate .</brief_summary>
	<brief_title>Focal Ablation Cervical Precancer</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Carcinoma Situ</mesh_term>
	<mesh_term>Cervical Intraepithelial Neoplasia</mesh_term>
	<criteria>Age 2145 yo Biopsyconfirmed high grade cervical intraepithelial neoplasia grade 2 , 3 , 2/3 Satisfactory colposcopy , i.e. , entire transformation zone visible Lesion occupy &lt; = 2 quadrant cervix . Unsatisfactory colposcopy . Colposcopic lesion extend endocervical canal beyond colposcopic visualization . Endocervical curettage positive highgrade cervical intraepithelial neoplasia . Suspicion invasive cancer colposcopic exam . Glandular dysplasia atypical glandular cell cytology . Unreliable followup . Immunosuppression ( HIV , transplant recipient , etc . )</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>